Dr. Péter Ferdinandy, MD, PhD, MBA
Citizenship:
Hungarian
Date and place of birth:
1966, Békéscsaba
Email: sci.vicerector@semmelweis-univ.hu
Current positions
| 2018 – ongoing | Vice-Rector for Science and Innovations, Semmelweis University |
| 2011 -ongoing |
Professor & Director, Department of Pharmacology and Pharmacotherapy, Medical Faculty – Semmelweis University, Budapest, Hungary. |
| 2005 – 2019 | Professor of Biochemistry (part-time), Head of the Cardiovascular Research Group – University of Szeged, Hungary |
| 2003 – ongoing | Founder and CEO of Pharmahungary Group, Szeged, Hungary (spin-off companies) |
Education and Scientific degrees
| 2004 | DSc in medical sciences, Hungarian Academy of Sciences |
| 2000-2004 | MBA (Masters of Business Administration, Finance and Quality management), Budapest Technical University, Hungary |
| 1999 | Designation as registered Clinical-Pharmacologist |
| 1997-1999 | Postdoctoral training, Dept Pharmacology, University of Alberta, Edmonton, Canada |
| 1995 December |
PhD in biochemistry (score: excellent, “summa cum laude”) |
| 1991-1995 | PhD training, Departments of Physiology and Biochemistry, University of Szeged, Hungary |
| 1991 September | MD diploma (score: excellent, “summa cum laude”) |
| 1985-1991 | University of Szeged, Hungary |
Teaching experience:
| 2004- | Lecturer in Pharmacology, Semmelweis University, Budapest |
| 1993- | Lecturer in Biochemistry, University of Szeged, Hungary |
| 1998-1999 | Lecturer in Pharmacology, University of Alberta, Edmonton, Canada |
| 1991-1994 | Lecturer in Physiology, University of Szeged, Hungary |
Scholarships, fellowships
|
1989-1991 Scholarship of Hungarian Republic |
| 1997-1999: Postdoc Fellow, MRC Canada, University of Alberta, Canada |
|
2001-2005 Szechenyi professorship, Hungarian Academy of Sciences |
| 2013-2014 Szentagothai professorship, National Excellence Program |
Major awards
First prize, Young Investigator Award 1999, International Society for Heart Research
Major leadership positions at international scientific organizations
| President (2012-2014) |
International Society for Heart Research, European Section |
| Chairman (2014-2016) |
Working Group Cell Biology of the Heart, European Cardiology Society |
| President(2019-2023) | Hungarian Society of Experimental and Clinical Pharmacology |
Editorial board memberships
- Editor-in-Chief: British Journal of Pharmacology, from Jan 1, 2023
- Br J Pharmacol (Reviews Editor, Guest Editor, impakt factor 4.9)
- J Mol Cell Cardiol (Editor, impakt factor 5.1)
- Basic Res Cardiol (Editor, impakt factor 5.9)
- J Pharmacol Tox Methods (Editor, impakt factor 2.2)
- Vascular Pharmacology (Editor, impakt factor 3.7)
Languages
- Native language: Hungarian
- English (fluent)
- German (basic understanding)
Scientometric data
- Number of papers in international peer-reviewed journals: over 340 (source: PubMed)
- Cumulative impact factor of full papers: over 1600
- Total number of citations: over 23000, Hirsch index: 75 (source: Google Scholar)
- Patent families: 6, software developments: 3 on the market
- Listed on HIGHLYCITED researchers in 2014; 2017, 2020, 2021, 2022, 2023 (list of the most influential “highly cited” scientists)